21th Annual Meeting – of the Working Group “Experimental Neuro-Oncology”

Abstracts (HTML) List of Authors

Ahangarian Abhari, B

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Alkassar, M

Combining DC-mediated immunotherapy with oncolytic virotherapy in the treatment of HGG

Bangert, A

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Barckhausen, C

DNA Damaging Drugs in the Treatment of Glioblastoma: HR, Apoptosis, Autophagy and Senescence

Bender, S

Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53

Benner, A

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Borchardt, C

Effects of histone methyltransferase inhibitor 3-Deazaneoplanocin (DZNep) on rhabdoid tumor cell lines

Cin, H

Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma

Classen, CF

Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide

Clemens, D

Effects of histone methyltransferase inhibitor 3-Deazaneoplanocin (DZNep) on rhabdoid tumor cell lines

Cristofanon, S

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Debatin, KM

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Deimling, A von

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Deubzer, HE

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

De Vleeschouwer, S

Combining DC-mediated immunotherapy with oncolytic virotherapy in the treatment of HGG
Immunotherapy for high grade glioma: current clinical practice for patients with (relapsed) GBM

Dünisch, P

Establishing short term cultures from human brain tumours and metastases to analyze reduction of cell proliferation by antitumoural drugs

Eckhardt, I

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Erdlenbruch, B

Editorial

Ewald, C

Establishing short term cultures from human brain tumours and metastases to analyze reduction of cell proliferation by antitumoural drugs

Farwick, N

Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Freitag, D

Establishing short term cultures from human brain tumours and metastases to analyze reduction of cell proliferation by antitumoural drugs

Frühwald, MC

Effects of histone methyltransferase inhibitor 3-Deazaneoplanocin (DZNep) on rhabdoid tumor cell lines
Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Fulda, S

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Gielen, GH

Identification of p53 accumulation, EGFR gain and PDGFRα gain/amplification as adverse prognostic factors in pediatric high grade gliomas – evaluation of 48 cases of the German HIT-HGG trial

Glasow, A

Combinatorial effects of Resveratrol, 5-aza-2'deoxycytidin, and irradiation on clonogenic survival and stem cell population in human Medulloblastoma cell lines
Photodynamic treatment with Tetrahydroporphyrin Tetratosylat induces programmed cell death in human glioblastoma cell lines

Graf, N

Combining DC-mediated immunotherapy with oncolytic virotherapy in the treatment of HGG

Gronych, J

Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma

Grube, S

Establishing short term cultures from human brain tumours and metastases to analyze reduction of cell proliferation by antitumoural drugs

Häcker, S

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Hambsch, P

Photodynamic treatment with Tetrahydroporphyrin Tetratosylat induces programmed cell death in human glioblastoma cell lines

Hari Krishna Vellanki, S

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Heiland, S

Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma

Hempel, G

Effects of histone methyltransferase inhibitor 3-Deazaneoplanocin (DZNep) on rhabdoid tumor cell lines

Herold-Mende, C

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Hielscher, T

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Jones, DTW

Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53

Josupeit, R

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Jugold, M

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status

Jürgens, H

Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Kaina, B

DNA Damaging Drugs in the Treatment of Glioblastoma: HR, Apoptosis, Autophagy and Senescence

Kalff, R

Establishing short term cultures from human brain tumours and metastases to analyze reduction of cell proliferation by antitumoural drugs

Kerl, K

Effects of histone methyltransferase inhibitor 3-Deazaneoplanocin (DZNep) on rhabdoid tumor cell lines

Kern, S

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Knizhnik, A

DNA Damaging Drugs in the Treatment of Glioblastoma: HR, Apoptosis, Autophagy and Senescence

Koks, C

Combining DC-mediated immunotherapy with oncolytic virotherapy in the treatment of HGG

Kolodziej, S

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Kool, M

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Korshunov, A

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Kortmann, RD

Combinatorial effects of Resveratrol, 5-aza-2'deoxycytidin, and irradiation on clonogenic survival and stem cell population in human Medulloblastoma cell lines
Photodynamic treatment with Tetrahydroporphyrin Tetratosylat induces programmed cell death in human glioblastoma cell lines

Kramm, C

Identification of p53 accumulation, EGFR gain and PDGFRα gain/amplification as adverse prognostic factors in pediatric high grade gliomas – evaluation of 48 cases of the German HIT-HGG trial

Kulozik, AE

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Lacroix, J

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Lausen, J

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc- mediated downregulation of cFLIP

Leuchs, B

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Lichter, P

Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53

Lodrini, M

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Mack, SC

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Milde, T

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells
The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Milford, D

Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma

Mullins, C

Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide

Oehme, I

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Patties, I

Combinatorial effects of Resveratrol, 5-aza-2'deoxycytidin, and irradiation on clonogenic survival and stem cell population in human Medulloblastoma cell lines

Pauwels, F

Immunotherapy for high grade glioma: current clinical practice for patients with (relapsed) GBM

Pfaff, E

Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53

Pfister, S

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status

Pfister, SM

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells
Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Piek, J

Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide

Pietsch, T

Identification of p53 accumulation, EGFR gain and PDGFRα gain/amplification as adverse prognostic factors in pediatric high grade gliomas – evaluation of 48 cases of the German HIT-HGG trial

Plagemann, T

Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Quiros, S

DNA Damaging Drugs in the Treatment of Glioblastoma: HR, Apoptosis, Autophagy and Senescence

Richter, G

Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Rommelaere, J

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Roos, WP

DNA Damaging Drugs in the Treatment of Glioblastoma: HR, Apoptosis, Autophagy and Senescence

Schastak, S

Photodynamic treatment with Tetrahydroporphyrin Tetratosylat induces programmed cell death in human glioblastoma cell lines

Schlehofer, JR

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Schlosser, S

Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Schlund, F

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells

Schubert, J

Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide

Taylor, MD

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Tzaridis, TD

Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53

Unland, R

Effects of histone methyltransferase inhibitor 3-Deazaneoplanocin (DZNep) on rhabdoid tumor cell lines
Epigenetic silencing of the Dopamine Receptor D4 in medulloblastoma

Van Gool, S

Combining DC-mediated immunotherapy with oncolytic virotherapy in the treatment of HGG
Immunotherapy for high grade glioma: current clinical practice for patients with (relapsed) GBM

Walter, J

Establishing short term cultures from human brain tumours and metastases to analyze reduction of cell proliferation by antitumoural drugs

Witt, H

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells
The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Witt, O

Parvovirus H-1 (H-1PV) exerts oncolytic effects in cell culture models of human brain tumor-initiating cells
The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status
Investigation of BRAF fusion genes as a therapeutic target in pilocytic astrocytoma
Actinomycin-D treatment of high-risk ependymomas re-establishes the apoptotic function of p53
Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

Zucknick, M

The Pediatric Brain Tumor Preclinical Testing Program: an update on the current status

zur Mühlen, A

Identification of p53 accumulation, EGFR gain and PDGFRα gain/amplification as adverse prognostic factors in pediatric high grade gliomas – evaluation of 48 cases of the German HIT-HGG trial